Palatin: An Investment Waiting to Happen?

Palatin Technologies (AMEX:PTN) has been making recent advancements in biopharmaceutical research and development, and investors are thinking about cashing in. Palatin has even formed partnerships with King Pharmaceuticals (NYSE:KG) and Mallinckrodt Imaging (a subsidiary of Tyco Healthcare). New products are making the future of Palatin look bright. Is Palatin a great investment opportunity waiting to happen?

A new melanocortin receptor agonist that is currently in development, known as PT-141 (also Bremelanotide), could be the next big thing in pharmaceuticals. This drug, already tested through two phases of study, will treat sexual dysfunction in both males and females. Should trial studies continue to be successful, this sort of drug stands to make a big splash on the open market. Once released to the public, Bremelanotide could become huge.

Safety studies and efficacy studies (Phase 1 and Phase 2) have gone well, and in August 2004 Palatin and King Pharmaceuticals joined to commercially develop the new drug. At-home studies will complete Phase 3 of testing. So far, studies seem to show that PT-141 (Bremelanotide) may effectively treat erectile dysfunction without negative effects to the cardiovascular system. According to Palatin, more than three hundred (300) men have been tested using this drug, with positive results.

The success of similar drugs sheds a promising light on the future of Palatin and Bremelanotide. So far, clinical trials and studies are showing great results, and investors are looking forward to the future of Palatin. The treatment of sexual dysfunction is still new, and there arent a lot of drugs on the market. Bremelanotide, which will act as an effective treatment for both sexes, stands a good chance of becoming the most popular drug for sexual dysfunction.

Is Palatin Technologies a big investment opportunity waiting to happen? Keep an eye on this growing company, and on any new products that theyre working on. Bremelanotide, as well as other Palatin products, could make stocks rise astronomically. Staying on top of new companies and products is a good way to stay on top of the market itself.